AXSM ▲ +3.6% - Axsome Therapeutics, Inc. $AXSM reported Q3 2026 EPS of -$0.25, beating the -$0.64 estimate by 60.9%. Revenue of $259.7M beat the $248.6M estimate by 4.4% 02-NOV-2026 07:07 AM ET